159 related articles for article (PubMed ID: 7597306)
1. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
Stadler R; Otte HG
Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
[TBL] [Abstract][Full Text] [Related]
2. [Combination therapy with interferon alfa 2a and PUVA in cutaneous T-cell lymphoma].
Otte HG; Herges A; Stadler R
Hautarzt; 1992 Nov; 43(11):695-9. PubMed ID: 1468931
[TBL] [Abstract][Full Text] [Related]
3. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
[TBL] [Abstract][Full Text] [Related]
5. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
[TBL] [Abstract][Full Text] [Related]
6. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment for cutaneous lymphomas.
Mielke V; Staib G; Sterry W
Recent Results Cancer Res; 1995; 139():403-8. PubMed ID: 7597307
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
[No Abstract] [Full Text] [Related]
9. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma.
Zachariae H; Thestrup-Pedersen K
J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637
[TBL] [Abstract][Full Text] [Related]
10. Is interferon alpha in cutaneous T-cell lymphoma a treatment of choice?
Papa G; Tura S; Mandelli F; Vegna ML; Defazio D; Mazza P; Zinzani PL; Simoni R; DePita O; Ferranti G
Br J Haematol; 1991 Oct; 79 Suppl 1():48-51. PubMed ID: 1931709
[TBL] [Abstract][Full Text] [Related]
11. Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.
Rupoli S; Barulli S; Guiducci B; Offidani M; Mozzicafreddo G; Simonacci M; Filosa G; Giacchetti A; Ricotti G; Brandozzi G; Cataldi I; Serresi S; Ceschini R; Bugatti L; Offidani A; Giangiacomi M; Brancorsini D; Leoni P
Haematologica; 1999 Sep; 84(9):809-13. PubMed ID: 10477454
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma.
Chiarion-Sileni V; Bononi A; Fornasa CV; Soraru M; Alaibac M; Ferrazzi E; Redelotti R; Peserico A; Monfardini S; Salvagno L
Cancer; 2002 Aug; 95(3):569-75. PubMed ID: 12209749
[TBL] [Abstract][Full Text] [Related]
13. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma.
Fimiani M; Rubegni P; De Aloe G; Andreassi L
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):502-3. PubMed ID: 10459134
[No Abstract] [Full Text] [Related]
14. The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-alpha 2a and etretinate.
Dréno B; Claudy A; Meynadier J; Verret JL; Souteyrand P; Ortonne JP; Kalis B; Godefroy WY; Beerblock K; Thill L
Br J Dermatol; 1991 Nov; 125(5):456-9. PubMed ID: 1751352
[TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy of cutaneous T-cell lymphoma at special sites].
Eich D; Eich HT; Otte HG; Ghilescu V; Stadler R
Hautarzt; 1999 Feb; 50(2):109-14. PubMed ID: 10097953
[TBL] [Abstract][Full Text] [Related]
16. International symposium on cutaneous T cell lymphoma. Chicago, Illinois, Oct. 19-21, 1989.
Springer EA; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1991 Jan; 24(1):136-8. PubMed ID: 1999510
[No Abstract] [Full Text] [Related]
17. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a.
Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.
Kuzel TM; Gilyon K; Springer E; Variakojis D; Kaul K; Bunn PA; Evans L; Roenigk HH; Rosen ST
J Natl Cancer Inst; 1990 Feb; 82(3):203-7. PubMed ID: 2296050
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
[TBL] [Abstract][Full Text] [Related]
20. Combination of local PUVA-therapy and interferon alpha-2A in the treatment of tumoral stage mycosis fungoides.
Delpuget-Bertin N; Bernard P; Bedane C; Dang PM; Bonnetblanc JM
Dermatology; 1996; 193(1):74-5. PubMed ID: 8864634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
